EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Exposure levels and target attainment of meropenem in adult patients admitted to the intensive care unit: a prospective observational study

Ibrahim El-Haffaf iD, Amélie Marsot, Alice Paillault, Viviane Giang, Virginie Williams, Marc-André Smith, Martin Albert, Michael Chassé, David Williamson

Canadian Journal of Physiology and Pharmacology · 2025

DOI: 10.1139/cjpp-2025-0028 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Canadian Journal of Physiology and Pharmacology, 2025. Verfasst von Ibrahim El-Haffaf und 8 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Université de Montréal, Montreal, QC, Canada. Hauptthemen laut MEDLINE: Meropenem, Intensive Care Units, Anti-Bacterial Agents. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Society of Hospital Pharmacists, Fonds de Recherche du Québec-Santé, Faculté de pharmacie, Université de Montréal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this study, we evaluate the exposure and pharmacokinetic/pharmacodynamic target attainment of meropenem in critically ill patients. We conducted a prospective observational study in two Canadian intensive care units (ICUs) from January 2021 to December 2023. We included adult patients admitted in the ICU who received meropenem. On study days 1, 4, and 7 of antimicrobial therapy, three blood samples were collected: 1 h after end of infusion, at the middle, and at the end of the dosing interval. Samples were analyzed by ultra-high performance liquid chromatography with diode array detector. The pharmacokinetic profile of meropenem was evaluated, as well as the attainment of serum concentrations above minimum inhibitory concentrations of 2, 4, and 8 mg/L at midpoint and at trough. We enrolled 28 patients and analyzed 167 meropenem concentrations. We observed large interindividual variability, but intraindividual variability was low. At midpoint, 52% of concentrations were below the target concentration of 8 mg/L, while this proportion increased to 73% for trough concentrations. Patients who failed to reach therapeutic concentrations all had normal to increased renal function. The majority of ICU patients who received meropenem were underexposed for a target concentration of 8 mg/L, with notable interindividual variability but low intraindividual variability. More aggressive dosing administration protocols are warranted to facilitate target attainment of meropenem.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MeropenemIntensive Care UnitsAnti-Bacterial AgentsHumansMaleFemaleProspective StudiesMiddle AgedAgedCritical IllnessMicrobial Sensitivity TestsAdultCanada

Stichwörter der Autor:innen

intensive care unitmeropenempharmacokineticstherapeutic drug monitoring

Substanzen

MeropenemAnti-Bacterial Agents

Autor:innen und Institutionen

  • Faculty of Pharmacy, Université de Montréal, Montreal, QC, Canada.
  • Laboratoire de Suivi Thérapeutique Pharmacologique et Pharmacocinétique, Faculty of Pharmacy, Université de Montréal, Montreal, QC, Canada.
  • Centre de recherche, CHU Sainte-Justine, Montreal, QC, Canada.
  • CIUSSS-NIM-Hôpital du Sacré-Cœur de Montréal and CIUSSS-NIM Research Center, Montreal, QC, Canada.
  • Faculty of Medicine, Université de Montréal, Montreal, QC, Canada.
  • Centre Hospitalier de l'Université de Montréal and CHUM Research Center, Montreal, QC, Canada.

ORCID-Profile: Ibrahim El-Haffaf

Förderung

  • Canadian Society of Hospital Pharmacists
  • Fonds de Recherche du Québec-Santé
  • Faculté de pharmacie, Université de Montréal
  • Canadian Institutes of Health Research

Zitieren

APA

El-Haffaf, I., Marsot, A., Paillault, A., Giang, V., Williams, V., Smith, M., Albert, M., Chassé, M., & Williamson, D. (2025). Exposure levels and target attainment of meropenem in adult patients admitted to the intensive care unit: a prospective observational study. Canadian Journal of Physiology and Pharmacology. https://doi.org/10.1139/cjpp-2025-0028

Vancouver

El-Haffaf I, Marsot A, Paillault A, Giang V, Williams V, Smith M, et al. Exposure levels and target attainment of meropenem in adult patients admitted to the intensive care unit: a prospective observational study. Canadian Journal of Physiology and Pharmacology. 2025. doi:10.1139/cjpp-2025-0028

BibTeX
@article{ElHaffaf2025,
  author = {El-Haffaf, Ibrahim and Marsot, Amélie and Paillault, Alice and Giang, Viviane and Williams, Virginie and Smith, Marc-André and Albert, Martin and Chassé, Michael and Williamson, David},
  title = {Exposure levels and target attainment of meropenem in adult patients admitted to the intensive care unit: a prospective observational study},
  journal = {Canadian Journal of Physiology and Pharmacology},
  year = {2025},
  doi = {10.1139/cjpp-2025-0028}
}
Kostenlos starten →